Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$4.15M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$5.2M$10.5M2025 · bought $0 · sold $10.5M20252026 · bought $0 · sold $3.5M2026
Total +$0.0000 bought · $13.93M sold

All filings on record

Every Form 4 transaction we track for this filer

NBIXGift
2026-06-05 · NEUROCRINE BIOSCIENCES INC
2,441
NBIXSell
2026-06-01 · NEUROCRINE BIOSCIENCES INC
$1.76M
NBIXExercise
2026-06-01 · NEUROCRINE BIOSCIENCES INC
$932.1K
NBIXSell
2026-05-27 · NEUROCRINE BIOSCIENCES INC
$1.71M
NBIXExercise
2026-05-27 · NEUROCRINE BIOSCIENCES INC
$932.1K
NBIXGift
2026-02-20 · NEUROCRINE BIOSCIENCES INC
3,110
NBIXTax
2026-02-13 · NEUROCRINE BIOSCIENCES INC
$1.33M
NBIXGrant
2026-02-13 · NEUROCRINE BIOSCIENCES INC
19,935
NBIXTax
2026-02-13 · NEUROCRINE BIOSCIENCES INC
$182.0K
NBIXExercise
2026-02-13 · NEUROCRINE BIOSCIENCES INC
2,717
NBIXTax
2026-02-13 · NEUROCRINE BIOSCIENCES INC
$180.2K
NBIXExercise
2026-02-13 · NEUROCRINE BIOSCIENCES INC
2,690
NBIXTax
2026-02-12 · NEUROCRINE BIOSCIENCES INC
$175.5K
NBIXExercise
2026-02-12 · NEUROCRINE BIOSCIENCES INC
2,560
NBIXTax
2026-01-31 · NEUROCRINE BIOSCIENCES INC
$19.3K
NBIXExercise
2026-01-31 · NEUROCRINE BIOSCIENCES INC
238
NBIXTax
2025-11-29 · NEUROCRINE BIOSCIENCES INC
$342.1K
NBIXExercise
2025-11-29 · NEUROCRINE BIOSCIENCES INC
4,426
NBIXGift
2025-09-03 · NEUROCRINE BIOSCIENCES INC
1,470
NBIXGift
2025-08-05 · NEUROCRINE BIOSCIENCES INC
3,116
NBIXSell
2025-07-09 · NEUROCRINE BIOSCIENCES INC
$7.80M
NBIXExercise
2025-07-09 · NEUROCRINE BIOSCIENCES INC
$5.07M
NBIXSell
2025-07-02 · NEUROCRINE BIOSCIENCES INC
$2.65M
NBIXExercise
2025-07-02 · NEUROCRINE BIOSCIENCES INC
$1.73M

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.